Screener
LeMaitre Vascular LMAT Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by LeMaitre Vascular in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: LeMaitre Vascular’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 6:30 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333762
| Line item | Three months ended / June 30, 2026 | Three months ended / June 30, 2025 | Six months ended / June 30, 2026 | Six months ended / June 30, 2025 |
|---|---|---|---|---|
| General and administrative | 11,110 | 10,396 | 23,156 | 20,883 |
| Research and development | 4,847 | 3,541 | 8,907 | 7,636 |
| Total operating expenses | 30,365 | 28,832 | 60,986 | 57,626 |
| Income from operations | 20,399 | 16,142 | 38,174 | 28,768 |
| Other income (expense): | ||||
| Investment income | 3,386 | 2,980 | 6,710 | 5,883 |
| Interest expense | (1,302) | (1,299) | (2,602) | (2,589) |
| Other (loss) income, net | (294) | 247 | (421) | 249 |
Item 1. Financial Statements
FAQ
- What is LeMaitre Vascular's operating income?
- LeMaitre Vascular (LMAT) reported operating income of $20.4M in Q2 2026.
- How has LeMaitre Vascular's operating income changed year-over-year?
- LeMaitre Vascular's operating income increased by 26.4% year-over-year, from $16.14M to $20.4M.
- What is the long-term trend for LeMaitre Vascular's operating income?
- Over 4 years (2021 to 2025), LeMaitre Vascular's operating income has grown at a 16.9% compound annual growth rate (CAGR), from $36.43M to $67.91M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.
Ask your AI about LeMaitre Vascular's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude